Investig Clin Urol.  2017 Mar;58(2):117-126. 10.4111/icu.2017.58.2.117.

Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia

• Gangkak G
• Bhattar R
• Mittal A
• Yadav SS
• Tomar V
• Yadav A
• Mehta J

• KMID: 2368477
• DOI: http://doi.org/10.4111/icu.2017.58.2.117

Abstract

PURPOSE
Estrogens act through interaction with 2 receptor subtypes, ER alpha (ERα) and ER beta (ERβ), in human prostate. The aim of the present study was to semiquantitatively assess the differential expression of ER subtypes in human benign prostatic hyperplasia (BPH) by use of immunocytochemistry (IHC) methods and to explore their relationship with various measures of BPH.
MATERIALS AND METHODS
A total of 45 patients with BPH undergoing transurethral resection of the prostate and 22 patients with bladder cancer with normal prostate undergoing surveillance cystoscopy were studied as cases and controls, respectively. Quantitative immunolabeling of ER subtypes was scored by use of a semiquantitative scale. Also, correlations were assessed between ER levels in prostate and various measures of BPH.
RESULTS
Overall, we found strong immunostaining for ERα in stroma and for ERβ in epithelium, respectively. The IHC score for ERα differed significantly between BPH patients and controls in both stroma (p≤0.001) and epithelium (p=0.008), respectively. The ERβ IHC score was also significantly higher in the epithelium of BPH patients (p=0.01). Also, we found a significant correlation between prostatic ER levels and various clinical measures of BPH.
CONCLUSIONS
ERs may play an important role in the pathogenesis of BPH.

Keyword

Antibodies; Estrogens; Immunohistochemistry; Prostate

MeSH Terms

Antibodies
Cystoscopy
Epithelium
Estrogens*
Humans
Immunohistochemistry
Male
Prostate*
Prostatic Hyperplasia*
Receptors, Estrogen*
Urinary Bladder Neoplasms
Antibodies
Estrogens
Receptors, Estrogen

Figure

• 

  Fig. 1 Positive controls for estrogen receptors (ERs). Breast cancer tissue for ER alpha (A) and hypothalamus tissue sections for ER beta (B) were taken as positive controls (H&E, ×40).

• 

  Fig. 2 Immunohistochemical analysis of estrogen receptor (ER) subtypes and Ki-67 expression in prostatic specimens from benign prostatic hyperplasia (BPH) patients (A, C, E, G) and controls (B, D, F, H). (A) Section from BPH specimens shows positive immunostaining (red arrow) for ER beta (ERβ) (H&E, ×40). (B) Representative area from normal prostate shows absence of ERβ immunostaining (H&E, ×40). (C) Intense ERβ positivity was primarily localized to epithelial nuclei (black pointer) in BPH tissues, whereas (D) nuclear staining was sparse (blue arrow) and seen mostly in epithelium of normal prostates (C, D: H&E, ×400). (E) In BPH specimens, immunoreactivity for ER alpha (ERα) was intensely expressed in both epithelial and stromal compartments. Note the close proximity between immunoreactive epithelial and stromal cells (black pointer and yellow arrow) (H&E, ×400). (F) ERα was expressed with much lower intensity in both stromal and epithelial compartments in controls (H&E, ×400). (G) Abundant nuclear staining for Ki-67 (yellow arrow) was found in BPH specimens, whereas (H) a representative area from normal prostate shows absent staining (G, H: H&E, ×400).

• 

  Fig. 3 Comparison of immunocytochemistry (IHC) scores of both estrogen receptor (ER) subtypes in benign prostatic hyperplasia (BPH) patients vs. normal controls. *Significant difference (p<0.05).

• 

  Fig. 4 Significant correlation between various measures of benign prostatic hyperplasia (BPH) and estrogen receptor (ER) in prostatic stroma and epithelium. (A) ER alpha (ERα) in stroma vs. age (r=0.37). (B) ERα in stroma vs. prostate-specific antigen (PSA) (r=0.32). (C) ERα in epithelium vs. International Prostate Symptom Score (IPSS) (r=0.32). (D) ERα in epithelium vs. prostate size (r=0.38). (E) ERα in stroma vs. prostate size (r=0.51). (F) ERα in epithelium vs. serum estradiol (r=0.53). (G) ER beta (ERβ) in epithelium vs. serum estradiol (r=0.56). A p-value of <0.05 was considered statistically significant.

Reference

1. Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am. 1990; 17:495–507.

2. Castagnetta LA, Carruba G. Human prostate cancer: a direct role for oestrogens. In : Bock GR, Goode JA, editors. Non-reproductive actions of sex steroids. Chichester: John Wiley Sons;1995. p. 269–289.

3. Prins GS, Korach KS. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids. 2008; 73:233–244.

4. Risbridger GP, Bianco JJ, Ellem SJ, McPherson SJ. Oestrogens and prostate cancer. Endocr Relat Cancer. 2003; 10:187–191.

5. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science. 1986; 231:1150–1154.

6. Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996; 392:49–53.

7. Tsurusaki T, Aoki D, Kanetake H, Inoue S, Muramatsu M, Hishikawa Y, et al. Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia. J Clin Endocrinol Metab. 2003; 88:1333–1340.

8. Schulze H, Claus S. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. Prostate. 1990; 16:331–343.

9. Brenner RM, West NB, McClellan MC. Estrogen and progestin receptors in the reproductive tract of male and female primates. Biol Reprod. 1990; 42:11–19.

10. Royuela M, de Miguel MP, Bethencourt FR, Sánchez-Chapado M, Fraile B, Arenas MI, et al. Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate. J Endocrinol. 2001; 168:447–454.

11. Ehara H, Koji T, Deguchi T, Yoshii A, Nakano M, Nakane PK, et al. Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate. 1995; 27:304–313.

12. Prins GS, Marmer M, Woodham C, Chang W, Kuiper G, Gustafsson JA, et al. Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology. 1998; 139:874–883.

13. Mäkelä S, Strauss L, Kuiper G, Valve E, Salmi S, Santti R, et al. Differential expression of estrogen receptors alpha and beta in adult rat accessory sex glands and lower urinary tract. Mol Cell Endocrinol. 2000; 164:109–116.

14. Fixemer T, Remberger K, Bonkhoff H. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate. 2003; 54:79–87.

15. Lau KM, LaSpina M, Long J, Ho SM. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res. 2000; 60:3175–3182.

16. Fujimura T, Takahashi S, Urano T, Ogawa S, Ouchi Y, Kitamura T, et al. Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer. Biochem Biophys Res Commun. 2001; 289:692–699.

17. Nicholson TM, Sehgal PD, Drew SA, Huang W, Ricke WA. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment. Differentiation. 2013; 85:140–149.

18. Weihua Z, Warner M, Gustafsson JA. Estrogen receptor beta in the prostate. Mol Cell Endocrinol. 2002; 193:1–5.

19. Prins GS, Birch L, Couse JF, Choi I, Katzenellenbogen B, Korach KS. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res. 2001; 61:6089–6097.

20. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development. 2000; 127:4277–4291.

21. Nicholson TM, Moses MA, Uchtmann KS, Keil KP, Bjorling DE, Vezina CM, et al. Estrogen receptor-α is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasia. J Urol. 2015; 193:722–729.

22. Allred DC, Bustamante MA, Daniel CO, Gaskill HV, Cruz AB Jr. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance. Arch Surg. 1990; 125:107–113.

23. Pasquali D, Staibano S, Prezioso D, Franco R, Esposito D, Notaro A, et al. Estrogen receptor beta expression in human prostate tissue. Mol Cell Endocrinol. 2001; 178:47–50.

24. Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, et al. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol. 2001; 159:79–92.

25. Shapiro E, Huang H, Masch RJ, McFadden DE, Wilson EL, Wu XR. Immunolocalization of estrogen receptor alpha and beta in human fetal prostate. J Urol. 2005; 174:2051–2053.

26. Buchanan DL, Kurita T, Taylor JA, Lubahn DB, Cunha GR, Cooke PS. Role of stromal and epithelial estrogen receptors in vaginal epithelial proliferation, stratification, and cornification. Endocrinology. 1998; 139:4345–4352.

27. Risbridger G, Wang H, Young P, Kurita T, Wang YZ, Lubahn D, et al. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev Biol. 2001; 229:432–442.

28. Kozák I, Bartsch W, Krieg M, Voigt KD. Nuclei of stroma: site of highest estrogen concentration in human benign prostatic hyperplasia. Prostate. 1982; 3:433–438.

29. Imamov O, Morani A, Shim GJ, Omoto Y, Thulin-Andersson C, Warner M, et al. Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci U S A. 2004; 101:9375–9380.

30. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A. 1998; 95:15677–15682.